541 related articles for article (PubMed ID: 36756872)
1. Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation.
Butel-Simoes LE; Haw TJ; Williams T; Sritharan S; Gadre P; Herrmann SM; Herrmann J; Ngo DTM; Sverdlov AL
Hypertension; 2023 Apr; 80(4):685-710. PubMed ID: 36756872
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
3. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.
Lipshultz SE; Diamond MB; Franco VI; Aggarwal S; Leger K; Santos MV; Sallan SE; Chow EJ
Paediatr Drugs; 2014 Oct; 16(5):373-89. PubMed ID: 25134924
[TBL] [Abstract][Full Text] [Related]
4. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies.
Costanzo V; Ratre YK; Andretta E; Acharya R; Bhaskar LVKS; Verma HK
Curr Treat Options Oncol; 2024 Apr; 25(4):465-495. PubMed ID: 38372853
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review.
Madanat L; Gupta R; Weber P; Kumar N; Chandra R; Ahaneku H; Bansal Y; Anderson J; Bilolikar A; Jaiyesimi I
Curr Cardiol Rev; 2023; 19(3):e310522205428. PubMed ID: 35642110
[TBL] [Abstract][Full Text] [Related]
7. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity among adult survivors suffered from childhood malignancies.
Petropoulos AC; Moschovi M
Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
[TBL] [Abstract][Full Text] [Related]
9. Genetics of cancer therapy-associated cardiotoxicity.
Kim Y; Seidman JG; Seidman CE
J Mol Cell Cardiol; 2022 Jun; 167():85-91. PubMed ID: 35358500
[TBL] [Abstract][Full Text] [Related]
10. Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.
Wilcox NS; Rotz SJ; Mullen M; Song EJ; Ky Hamilton B; Moslehi J; Armenian SH; Wu JC; Rhee JW; Ky B
Circ Res; 2022 Feb; 130(4):632-651. PubMed ID: 35175846
[TBL] [Abstract][Full Text] [Related]
11. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
12. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
Tufano A; Coppola A; Galderisi M
Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review.
Upshaw JN
Curr Oncol Rep; 2020 Jun; 22(7):72. PubMed ID: 32564220
[TBL] [Abstract][Full Text] [Related]
14. Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions.
Chen JJ; Wu PT; Middlekauff HR; Nguyen KL
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H213-H222. PubMed ID: 27923793
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients.
van Dorst DCH; Dobbin SJH; Neves KB; Herrmann J; Herrmann SM; Versmissen J; Mathijssen RHJ; Danser AHJ; Lang NN
Circ Res; 2021 Apr; 128(7):1040-1061. PubMed ID: 33793337
[TBL] [Abstract][Full Text] [Related]
16. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.
Narayan V; Ky B
Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258
[TBL] [Abstract][Full Text] [Related]
17. Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors.
Sadurska E
Pediatr Cardiol; 2015 Aug; 36(6):1112-9. PubMed ID: 25939787
[TBL] [Abstract][Full Text] [Related]
18. New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies.
Lanza O; Ferrera A; Reale S; Solfanelli G; Petrungaro M; Tini Melato G; Volpe M; Battistoni A
Med Sci (Basel); 2022 May; 10(2):. PubMed ID: 35736347
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
[TBL] [Abstract][Full Text] [Related]
20. Cardio-Oncology in Childhood: State of the Art.
Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]